Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for lynch syndrome

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 5, 2009, Pages 600-604

  Van Lier, Margot G F ^a   De Wilt, Johannes H W ^a   Wagemakers, Jessie J M F ^b   Dinjens, Winand N M ^a   Damhuis, Ronald A M ^b   Wagner, Anja ^a   Kuipers, Ernst J ^a   Van Leerdam, Monique E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Rotterdam   (Netherlands)

Author keywords

Colorectal cance; Lynch syndrome; MSI analysis; Revised Bethesda Guidelines

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CLINICAL PRACTICE; COLORECTAL CANCER; FAMILIAL CANCER; FEMALE; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HOSPITAL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; AGE; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL TUMOR; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETIC SCREENING; GENETICS; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; NEEDLE BIOPSY; NEEDS ASSESSMENT; NETHERLANDS; NUCLEOTIDE SEQUENCE; PROBABILITY; PROGNOSIS; REGISTER; SEX DIFFERENCE; UTILIZATION REVIEW;

PROTEIN MUTS;

ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; COHORT STUDIES; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC SCREENING; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS DNA MISMATCH-BINDING PROTEIN; NEEDS ASSESSMENT; NEOPLASM STAGING; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; PROBABILITY; PROGNOSIS; REGISTRIES; SEX FACTORS;

EID: 67651085573     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802706008     Document Type: Article

References (25)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-8.
2. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
3. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
4. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118: 829-34.
5. de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006;130:665-71.
6. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
7. Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH, et al. Current clinical selection strategies for identification of hereditary nonpolyposis colorectal cancer families are inadequate: a metaanalysis. Clin Genet 2004;65:308-16.
8. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:1507-17.
9. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
10. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96: 261-8.
11. Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut 2005;54:97-102.
12. de Bruin JH, Ligtenberg MJ, Nagengast FM, Adang EM, van Krieken JH, Hoogerbrugge N. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update. Scand J Gastroenterol 2006;Suppl 243:146-52.
13. van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF. Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 2007;6:131-4.
14. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008;26(35):5783-8.
15. Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005;293(16):1986-94.
16. Rodriguez-Moranta F, Castells A, Andreu M, Pinol V, Castellvi-Bel S, Alenda C, et al. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol 2006;101: 1104-11.
17. Balmana J, Balaguer F, Castellvi-Bel S, Steyerberg EW, Andreu M, Llor X, et al. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 2008;45:557-63.
18. Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F, et al. Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer 2006;118: 1465-70.
19. Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007;133:48-56.
20. Church J, McGannon E. Family history of colorectal cancer: how often and how accurately is it recorded? Dis Colon Rectum 2000;43:1540-4.
21. Katballe N, Juul S, Christensen M, Orntoft TF, Wikman FP, Laurberg S. Patient accuracy of reporting on hereditary nonpolyposis colorectal cancer-related malignancy in family members. Br J Surg 2001;88:1228-33.
22. Sijmons RH, Boonstra AE, Reefhuis J, Hordijk-Hos JM, de Walle HE, Oosterwijk JC, et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 2000; 8:181-6.
23. de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005;4:233-7.
24. Schroy PC III, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 2002;97:1031-6.
25. Alberto VO, Harocopos CJ, Patel AA, Clark SK. Family and personal history in colorectal cancer patients: what are we missing? Colorectal Dis 2006;8:612-4.